PubMed Health⌕ Search

Biomedical subjects

F García González

Publications and source records attributed to F García González.

7 recordsLinked to original sources
PubMed1991

[The behavior of visceral proteins in digestive surgery patients undergoing total peripheral parenteral nutrition enriched with branched-chain amino acids (BCAA)].

The objective of this study, is to confirm a clear benefit of protein synthesis after administration of branched amino acids in parenteral nutrition solutions. Particularly, on a parenteral total hypocaloric nutrition including lipids. Eighty one digestive surgical patients, were included in this study. Fifty with neoplastic disease and thirty one without. Patients in both study groups received a similar peripheral vein nutritional support regimen one week after surgical treatment. To evaluate the effects of the branched chain amino acid enrichment on total parenteral nutrition, we observed the behavior of short middle life proteins such as transferrin, prealbumin, and retinol binding protein, for their reliability as indexes of protein synthesis.

Amino Acids, Branched-Chain↗
PubMedDate not supplied

Allergic dermatitis due to oral ebrotidine.

We report the case of a woman who developed generalized dermatitis after 1 week of treatment with ebrotidine, a new H2-receptor antagonist taken to prevent gastroduodenal lesions caused by nonsteroidal inflammatory drugs. Patch tests with ebrotidine and other H2-receptor antagonists ranitidine, cimetidine and famotidine were negative. Oral challenge test with ebrotidine showed the development of lesions similar to those appearing previously. Oral challenge test with ranitidine and cimetidine were negative, possibly due to the difference in the side chain chemical structure of ebrotidine and other H2-receptor antagonists. This is the first reported case of allergic dermatitis caused by ebrotidine.

Administration, Oral↗
PubMedDate not supplied

[Cost-minimization study on the prescription of intravenous proton pump inhibitors: pantoprazole versus omeprazole].

OBJECTIVE: To compare and quantify intravenous omeprazole versus intravenous pantoprazole prescription habits in common acid-related diseases such as gastro-esophageal reflux disease, duodenal ulcer, and gastric ulcer. MATERIAL AND METHODS: We designed an observational, longitudinal prospective and multicenter cost-minimization study to be carried out in Spanish hospitals. RESULTS: The pantoprazole regimen consisted of 40 mg/day (median), one half of that of omeprazole with 80 mg/day overall for these conditions (p < 0.05). This dosage was significantly different for duodenal ulcer (40.0 +/- 0.0 versus 90.6 +/- 22.5 mg/day, p < 0.05), and gastric ulcer (50.3 +/- 17.8 versus 85.8 +/- 39 mg/day, p < 0.05), but not for gastro-esophageal reflux disease (50.9 +/- 18.7 versus 62.2 +/- 21.1, p > 0.05). Costs for these regimens make treatments using pantoprazole 54% less expensive than treatments using omeprazole. By indication, the cost of duodenal ulcer treatment was 65% less expensive, and that of gastric ulcer 53% less expensive. CONCLUSIONS: Cost differences amount to approximately one half in treatments using pantoprazole, which is primarily due to the use of doses higher than indicated in treatments using intravenous omeprazole. To reduce expenses stemming from the inadequate use of intravenous proton pump inhibitors the use of pantoprazole is brought forward as a valid option.

2-Pyridinylmethylsulfinylbenzimidazoles↗
PubMedDate not supplied

[A preliminary study of total peripheral parenteral nutrition; with 65.5% branched-chain amino acids in surgical patients].

Presentation of the first results obtained from our study, the objective of which is to discover a benefit in the nutritional state following the administration of a greater amount of branched chain amino-acids in parenteral solutions using the peripheral method, during the first 7 days of the postoperative period, in neoplastic patients subjected to surgery of the digestive tract.

Aged↗